- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1559-1182
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Inhibition of LRRK2 or Casein Kinase 1 Results in LRRK2 Protein Destabilization ; day:27 ; month:12 ; year:2018 ; pages:1-14
Molecular neurobiology ; (27.12.2018), 1-14
- Creator
-
De Wit, T.
Baekelandt, V.
Lobbestael, E.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12035-018-1449-2
- URN
-
urn:nbn:de:101:1-2019021417280206923012
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:00 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- De Wit, T.
- Baekelandt, V.
- Lobbestael, E.
- SpringerLink (Online service)
Other Objects (12)
Exosome markers of LRRK2 kinase inhibition
LRRK2 kinase inhibition reverses G2019S mutation-dependent effects on tau pathology progression
Fibroblast Biomarkers of Sporadic Parkinson’s Disease and LRRK2 Kinase Inhibition
The LRRK2 signalling system
G2019S selective LRRK2 kinase inhibitor abrogates mitochondrial DNA damage
Mechanistic Insights into the intrinsic Kinase Regulation of LRRK2
LRRK2 kinase regulates α-synuclein propagation via RAB35 phosphorylation
Rab29 activation of the Parkinson's disease‐associated LRRK2 kinase
LRRK2 kinase inhibition prevents pathological microglial phagocytosis in response to HIV-1 Tat protein
Is inhibition of kinase activity the only therapeutic strategy for LRRK2-associated Parkinson's disease?
Elevated LRRK2 autophosphorylation in brain-derived and peripheral exosomes in LRRK2 mutation carriers
Functional characterization of leucine-rich repeat kinase 2 (LRRK2) dimerization
Exosome markers of LRRK2 kinase inhibition
LRRK2 kinase inhibition reverses G2019S mutation-dependent effects on tau pathology progression
Fibroblast Biomarkers of Sporadic Parkinson’s Disease and LRRK2 Kinase Inhibition
The LRRK2 signalling system
G2019S selective LRRK2 kinase inhibitor abrogates mitochondrial DNA damage
Mechanistic Insights into the intrinsic Kinase Regulation of LRRK2
LRRK2 kinase regulates α-synuclein propagation via RAB35 phosphorylation
Rab29 activation of the Parkinson's disease‐associated LRRK2 kinase
LRRK2 kinase inhibition prevents pathological microglial phagocytosis in response to HIV-1 Tat protein
Is inhibition of kinase activity the only therapeutic strategy for LRRK2-associated Parkinson's disease?
Elevated LRRK2 autophosphorylation in brain-derived and peripheral exosomes in LRRK2 mutation carriers
Functional characterization of leucine-rich repeat kinase 2 (LRRK2) dimerization
Exosome markers of LRRK2 kinase inhibition
LRRK2 kinase inhibition reverses G2019S mutation-dependent effects on tau pathology progression
Fibroblast Biomarkers of Sporadic Parkinson’s Disease and LRRK2 Kinase Inhibition
The LRRK2 signalling system
G2019S selective LRRK2 kinase inhibitor abrogates mitochondrial DNA damage
Mechanistic Insights into the intrinsic Kinase Regulation of LRRK2
LRRK2 kinase regulates α-synuclein propagation via RAB35 phosphorylation
Rab29 activation of the Parkinson's disease‐associated LRRK2 kinase
LRRK2 kinase inhibition prevents pathological microglial phagocytosis in response to HIV-1 Tat protein
Is inhibition of kinase activity the only therapeutic strategy for LRRK2-associated Parkinson's disease?
Elevated LRRK2 autophosphorylation in brain-derived and peripheral exosomes in LRRK2 mutation carriers